Daily as of 3 Nov 16:00 ET
- Price
- above both $461.26 vs 50 $420.83 / 200 $376.12
- Projection
- No cross projected
- Test
- No active test
- Last cross
- ๐จGolden cross 13 Nov 2025 ยท projected 29 bars out
Amgen (AMGN) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.
The 50 SMA has sat above the 200 on the daily since Nov 2025, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 9 Jul 2026 | ๐จGolden | 4-hour | 28 bars out | 3 bar cross test |
| 28 Apr 2026 | ๐Death | 4-hour | 20 bars out | 2 bar cross test |
| 13 Nov 2025 | ๐จGolden moderate | daily | 29 bars out | Not tested |
| 23 Oct 2025 | ๐จGolden | 4-hour | 24 bars out | 5 bar cross test |
| 2 Oct 2025 | ๐Death moderate | daily | 25 bars out | 1 bar cross test |
Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.